| Authors: |
Boeckmans J; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden; In Vitro Liver Disease Modelling team - Department of In Vitro Toxicology and Dermato-Cosmetology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: joost.boeckmans@vub.be., Widman L; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: linnea.widman@ki.se., Shang Y; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: ying.shang@ki.se., Strandberg R; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: rickard.strandberg@ki.se., Wester A; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: axel.wester@ki.se., Schattenberg JM; Department of Medicine II, University Medical Center Homburg, Homburg and Saarland University, Saarbrücken, Germany. Electronic address: joern.schattenberg@uks.eu., Hagström H; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden; Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden. Electronic address: hannes.hagstrom@ki.se. |
